Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Appl Radiat Isot ; 180: 110064, 2022 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-34923290

RESUMEN

The PSMA-targeted radionuclide therapy has been explored since 2015 with radioisotope lutetium-177, whose ß- emission range is adequate for micrometastases treatment. This radioisotope is obtained by two different production routes that directly affect the specific activity of lutetium-177 (non-carrier added and carrier added) and, consequently, the specific activity of radiopharmaceuticals, like 177Lu-PSMA-617. The influence of the specific activity of lutetium-177 on the properties of the radiopharmaceutical PSMA-617 was evaluated through pre-clinical studies. The in vitro study pointed to a lower constant of dissociation with non-carrier added lutetium-177 due to the difference in the specific activity. However, competition and internalization assays resulted in similar results for both lutetium-177. Based on these pre-clinical experiments, the total in vitro tumor cell binding and tumor uptake in vivo were similar, with no influence of the specific activity of the 177Lu-PSMA-617. Regardless the specific activity did not directly affect tumor uptake, the tumor/non-target organs ratios were higher for the radiopharmaceutical labeled with carrier added lutetium-177, which had the lowest specific activity.


Asunto(s)
Dipéptidos/farmacología , Compuestos Heterocíclicos con 1 Anillo/farmacología , Lutecio/química , Antígeno Prostático Específico/farmacología , Neoplasias de la Próstata/tratamiento farmacológico , Radioisótopos/química , Radiofármacos/química , Radiofármacos/farmacología , Animales , Línea Celular Tumoral , Humanos , Masculino , Ratones , Ratones SCID , Distribución Tisular , Ensayos Antitumor por Modelo de Xenoinjerto
2.
Bull Tokyo Dent Coll ; 57(1): 21-7, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-26961333

RESUMEN

Proper cleaning of the root canal is key to the success of endodontic treatment as it allows more effective diffusion of medication throughout the dentinal tubules. The aim of this in vitro study was to investigate the efficacy of 17% ethylenediaminetetraacetic acid (EDTA) in enhancing diffusion of hydroxyl (OH(-)) and calcium ions (Ca(2+)) throughout the root canal in primary teeth. The canals of 25 primary tooth roots were cleaned with endodontic files and 1% sodium hypochlorite. Three groups (G) were then established: GI, in which final irrigation was performed with 1% sodium hypochlorite; GII, in which 17% EDTA was used; and GIII, in which no irrigation was performed. The roots canals in GI and GII were filled with a calcium hydroxide-based paste labeled with the radioisotope calcium-45. Diffusion of OH(-) was detected with pH strips and Ca(2+) analyzed by measuring radioactivity in counts per min. Group II differed statistically from the other groups in diffusion of OH(-) at 24 hr (p<0.05), but no significant difference among groups was found at the day 7 evaluation; GII also differed statistically from the other groups in diffusion of Ca(2+) at 24 hr (p<0.05). These results suggest that application of 17% EDTA in primary tooth enhances diffusion of OH(-) and Ca(2+).


Asunto(s)
Cavidad Pulpar , Ácido Edético/farmacología , Irrigantes del Conducto Radicular/farmacología , Hidróxido de Calcio/farmacocinética , Humanos , Preparación del Conducto Radicular , Hipoclorito de Sodio/farmacocinética , Diente Primario
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA